BA/BE studies of Biologics and Biosimilars

 A biosimilar is a biologic therapeutic item which is duplicate of a unique item that is produced by an alternate organization. Biosimilars are authoritatively sanction forms of unique "discoverer" items, and can be produced when the first item's patent terminates. Reference to the pioneer item is a fundamental part of the approbation.

 

  • Bioanalytical Approaches
  • Cancer therapeutics
  • Cardiovascular therapeutics
  • Diabetes therapeutics
  • Adverse drug reactions with pharmaceutical products

Related Conference of BA/BE studies of Biologics and Biosimilars

December 14-14, 2020

2nd Pathology and Infectious Disease Conference

Dubai, UAE
March 28-29, 2021

11th Glycobiology World Congress

Vienna, Austria
April 24-24, 2021

2nd International Conference on Nucleic Acids

London, UK
June 11-12, 2021

25th Global Congress on Biotechnology

Berlin, Germany
September 13-14, 2021

17th World Congress on Structural Biology

Prague, Czech Republic
September 27-28, 2021

25th European Biotechnology Congress

Dublin, Ireland

BA/BE studies of Biologics and Biosimilars Conference Speakers

Recommended Sessions

Related Journals

Are you interested in